FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Sorrento Therapeutics Awarded NIH Grant for MRSA Program Company's innovative approach to developing vaccines and therapeutics for MRSA receives...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT...
Sorrento Therapeutics Announces Completion of Diverse Library of Full-Length, Fully Human Antibodies Industry-leading antibody development...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.